GNH USA

Europe — EMA

Ocplex

GNH USA supplies Ocplex (Human Coagulation Factor IX), a coagulation factor replacement therapy for hemophilia B. Request a quote for global supply.

Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F

Request sourcing

1
Pack/s

What is Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F?

Human Coagulation Factor IX (recombinant), the active ingredient in Ocplex, is a coagulation factor replacement therapy presented as a sterile solution for intravenous use. It treats hemophilia B by providing the missing clotting factor in affected individuals. GNH USA supplies Ocplex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Ocplex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F used for?

Ocplex is a recombinant coagulation factor used within the hemophilia B treatment pathway to replace deficient Factor IX.

- Hemophilia B: Provides temporary correction of Factor IX deficiency to control and prevent bleeding episodes. - Peri‑operative management: Supplies necessary Factor IX levels for surgical procedures in patients with hemophilia B. - Trauma‑induced bleeding: Offers rapid factor replacement to manage acute bleeding in hemophilia B patients.

What are the side effects of Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F?

Adverse reactions to recombinant Factor IX products are generally infrequent but can occur.

Common Side Effects: - Injection site erythema: Redness at the infusion site. - Mild headache: Transient head discomfort. - Low‑grade fever: Slight increase in body temperature. - Transient nausea: Short‑lasting feeling of nausea. - Fatigue: Generalized tiredness. - Mild arthralgia: Minor joint discomfort.

Serious or Rare Side Effects: - Anaphylaxis: Severe allergic reaction requiring immediate medical attention. - Development of inhibitors: Neutralizing antibodies that reduce drug efficacy. - Thromboembolic events: Blood clots forming in vessels. - Severe hypersensitivity: Rash, swelling, or respiratory distress. - Renal impairment: Deterioration of kidney function. - Hepatic dysfunction: Elevated liver enzymes or liver injury.

What precautions apply to Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F?

When using Ocplex, clinicians should observe several safety measures.

- Dosing individualized: Adjust dose based on patient’s Factor IX activity levels and clinical response. - Monitor inhibitors: Regularly test for anti‑Factor IX antibodies that may affect efficacy. - Bleeding surveillance: Observe for signs of uncontrolled bleeding or bruising. - Concomitant anticoagulants: Use caution when patients are also receiving anticoagulant therapy. - Pregnancy and lactation: Evaluate risk‑benefit ratio before administration. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F interact with?

Ocplex may interact with other agents that affect hemostasis.

Major Interactions (Avoid): - Direct oral anticoagulants (DOACs): May counteract the clotting effect of Factor IX. - Warfarin: Combined use can increase bleeding risk. - Antiplatelet agents (e.g., aspirin, clopidogrel): Heightened risk of hemorrhage.

Moderate Interactions (Monitor Closely): - Immunosuppressants: May influence inhibitor development. - Antibiotics such as vancomycin: Potential for altered immune response. - Intravenous immunoglobulin (IVIG): May affect pharmacokinetics of Factor IX.

Frequently asked questions

What is Ocplex used for?+
Ocplex is a recombinant human Factor IX product indicated to replace deficient clotting factor in patients with hemophilia B. It is used to control bleeding episodes, provide prophylactic coverage, and support surgical or traumatic situations where adequate hemostasis is required.
How does Human Coagulation Factor IX work in Ocplex?+
The recombinant Factor IX in Ocplex binds to phospholipid surfaces at vascular injury sites, forming part of the intrinsic tenase complex that activates Factor X. This cascade generates thrombin and fibrin, restoring normal clot formation in individuals lacking functional Factor IX.
What is the usual dose of Ocplex?+
Dosage is individualized by the prescribing clinician based on the patient’s Factor IX activity level, severity of bleeding, body weight, and clinical response. The prescriber determines the exact amount and frequency of administration.
Is Ocplex safe during pregnancy or breastfeeding?+
Safety data are limited, so the risk‑benefit profile should be carefully evaluated by the treating physician. Use is generally considered when the potential benefit to the mother outweighs any possible risk to the fetus or infant.
How do I order Ocplex from GNH USA?+
Submit an enquiry on the Ocplex product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.
How does Ocplex compare with other hemophilia B treatments?+
Ocplex is a recombinant Factor IX product, offering a purified, virus‑inactivated protein similar to other recombinant Factor IX therapies. Compared with plasma‑derived products, it reduces the risk of pathogen transmission and provides consistent potency, though dosing frequency and inhibitor risk may differ among brands.
What are the storage and handling requirements for Ocplex?+
Ocplex should be stored at 2‑8 °C, protected from light, and must not be frozen or shaken. Before use, inspect the vial for particulate matter or discoloration and allow it to reach room temperature if required for infusion.
How is Ocplex administered?+
Ocplex is given by intravenous infusion, typically through a peripheral or central line. The infusion rate and volume are determined by the prescriber, and the product must be administered under aseptic conditions by a qualified healthcare professional.
What are the most serious risks associated with Ocplex?+
The most serious risks include the development of neutralizing inhibitors that reduce efficacy, severe allergic reactions such as anaphylaxis, and rare thromboembolic events. Patients should be monitored closely for any signs of these reactions.
Who should not use Ocplex?+
Ocplex is contraindicated in patients with known hypersensitivity to any component of the formulation, including the recombinant protein or excipients. It should also be avoided in individuals with a history of severe inhibitor development unless benefits outweigh risks.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F
Route
Intravenous Use
Manufacturer
Octapharma (Ip) Sprl
Origin
EU